The landscape of genetic audiology has been significantly altered by a collaborative study led by King’s College London and George Washington University, which has successfully identified a new suite of…
For more than three decades, the cochlear implant has stood as the gold standard for neuroprosthetic success, restoring a sense of sound to hundreds of thousands of individuals worldwide. However,…
In a landmark study published in the journal Nature Cell Biology, a multidisciplinary team of scientists from Baylor College of Medicine, Texas Children’s Hospital, and the Hospital for Sick Children…
In a landmark study that challenges long-standing assumptions regarding the trajectory of neurodegenerative conditions, researchers at University College London (UCL) have discovered that individuals living with Alzheimer’s disease may retain,…
The fight against Alzheimer’s disease has long focused on pharmacological interventions, yet a landmark multi-site clinical trial has recently shifted the spotlight toward the profound preventative power of physical activity.…
A breakthrough in biomedical engineering at Boston University has yielded a new computational model that could fundamentally transform the lives of millions of individuals living with hearing impairment. By mimicking…
The medical community has long struggled to quantify the internal experience of tinnitus, a condition characterized by the perception of sound in the absence of an external source. For decades,…
The landscape of pediatric oncology is undergoing a transformative shift as new research identifies the precise developmental window and cellular origins of medulloblastoma, the most prevalent malignant brain tumor in…
The integration of hearing aids and professional audiological counseling into the standard of care for seniors may serve as a critical intervention in preserving social connections that typically diminish with…
The emergence of Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the landscape of oncology, offering a lifeline to patients with aggressive, treatment-resistant blood cancers. However, as the number of…
Lina Irawan